Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial

Author： Patrikidou A.   Chabaud S.   Ray-Coquard I.   Bui B. N.   Adenis A.   Rios M.   Bertucci F.   Duffaud F.   Chevreau C.   Cupissol D.   Domont J.   Prol D.   Blay J. Y.   Le Cesne A.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 1087-1093

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

By Bolla M.   Collette L.   Blank L.   Warde P.   Dubois J.B.   Mirimanoff R.-O.   Storme G.   Bernier J.   Kuten A.   Sternberg C.   Mattelaer J.   Lopez Torecilla J.   Pfeffer J.R.   Lino Cutajar C.   Zurlo A.   Pierart M.   Ritter M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 309-310

Elsevier

Access to resources Recommend Favorite

Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)

By Boni C.   Savoldi L.   Bisagni G.   Ceci G.   Crino L.   De Lisi V.   Di Costanzo F.   Lasagni L.   Manenti A.L.   Moretti G.   Rondini E.   Sassi M.   Zadro A.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1974-1976

Elsevier

Access to resources Recommend Favorite

Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 269-271

Informa Healthcare

Access to resources Recommend Favorite

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I.   Radford J.A.   Harris M.   Blay J.-Y.   van Hoesel Q.   le Cesne A.   van Oosterom A.T.   Clemons M.J.   Kamby C.   Hermans C.   Whittaker J.   Donato di Paola E.   Verweij J.   Nielsen S.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

By Namer M.   Soler-Michel P.   Turpin F.   Chinet-Charrot P.   de Gislain C.   Pouillart P.   Delozier T.   Luporsi E.   Etienne P.L.   Schraub S.   Eymard J.C.   Serin D.   Ganem G.   Calais G.   Maillart P.   Colin P.   Trillet-Lenoir V.   Prevost G.   Tigaud D.   Clavere P.   Marti P.   Romieu G.   Wendling J.L.  

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1132-1140

Elsevier

Access to resources Recommend Favorite